Apyx Medical Corporation
APYX
$0.8905
-$0.0191-2.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.59% | 28.26% | 13.46% | 21.14% | -107.54% |
| Total Depreciation and Amortization | -1.39% | -7.69% | -0.64% | 3.29% | -18.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.39% | -1.17% | -1.58% | -72.08% | 194.92% |
| Change in Net Operating Assets | 68.12% | -276.57% | 322.22% | -113.98% | -65.05% |
| Cash from Operations | 33.85% | -2.56% | 31.73% | -186.66% | -159.85% |
| Capital Expenditure | -60.13% | 47.06% | -725.71% | 62.37% | 46.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -60.13% | 47.06% | -725.71% | 62.37% | 46.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 99.95% | -84,784.62% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 372.11% |
| Cash from Financing | 135,300.00% | 0.00% | 0.00% | -100.02% | 14,439.02% |
| Foreign Exchange rate Adjustments | 323.88% | -452.63% | 72.73% | 152.38% | 32.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 179.91% | -1.32% | 27.72% | -129.60% | 488.73% |